The European Association for the Study of the Liver (EASL) is pleased to inform you of a broader and enhanced programme on the topic of Liver Cancer and has developed a new concept in the form of the EASL HCC Summit.
Taking place in Geneva, Switzerland from February 13-16, 2014, the programme will offer two sub-components. A Basic Science programme on Molecular Pathogenesis & Translational Research In Liver Cancer, immediately followed by the Clinical programme on Liver Cancer Management. This will result in a considerably broader scope of HCC topics aimed at a wider audience. Participants will be offered the option to attend either programmes or both.
We anticipate that this combination of high quality presentations together with the strong reputation of the invited speakers and the relevance of the topics will bring together leading researchers, academics, clinicians and scientists involved in HCC for what will be a memorable meeting.
We look forward to welcoming you in Geneva for this major event.
Scientific Organising Committee